Drug industry evading drug equivalency test works

Published: 2003-08-21 06:58:00

Updated: 2003-08-21 06:58:00

The drug industry paid more interests in the bio-equivalent tests than the works on drug equivalency proof for general drugs, which ultimately resulted in number of generic drugs being so declined that the generic drug dispensing enforced by the provisions would encounter with many hurdles.

Th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK